Prabhu Rajagopalan

Prabhu Rajagopalan

Bayer Crop Science - / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4400779
person_outline Prabhu Rajagopalan's MOST POPULAR ARTICLES
1-) Rogaratinib in patients with advanced cancers selected by FGFR mRNA expression: a phase 1 dose-escalation and dose-expansion study The Lancet Oncology 20 (10), 1454-1466, 2019
2-) Pharmacokinetics of a water-soluble fullerene in rats Antimicrobial agents and chemotherapy 40 (10), 2262-2265, 1996
3-) Effect of high‐fat breakfast and moderate‐fat evening meal on the pharmacokinetics of vardenafil, an oral phosphodiesterase‐5 inhibitor for the treatment of erectile dysfunction The Journal of Clinical Pharmacology 43 (3), 260-267, 2003
4-) First-in-human, multicenter, phase I dose-escalation and expansion study of anti-mesothelin antibody–drug conjugate anetumab ravtansine in advanced or metastatic solid tumorsR Hassan, GR Blumenschein Jr, KN Moore, AD Santin, HL Kindler, ...Journal of Clinical Oncology 38 (16), 1824-1835, 20201372020
5-) Effect of high‐fat breakfast and moderate‐fat evening meal on the pharmacokinetics of vardenafil, an oral phosphodiesterase‐5 inhibitor for the treatment of erectile dysfunctionP Rajagopalan, A Mazzu, C Xia, R Dawkins, P SundaresanThe Journal of Clinical Pharmacology 43 (3), 260-267, 20031242003